At Umedica, we are committed to delivering high-quality, affordable medicines with a strong emphasis on regulatory compliance and manufacturing excellence.
Our state-of-the-art manufacturing facility, located in Vapi, Gujarat (India), is approved by leading global health authorities, including:
This world-class facility is equipped with advanced technologies and automated systems, enabling the production of a wide range of pharmaceutical formulations, including:
Our broad product portfolio is designed with a patient-centric approach and spans multiple therapeutic categories, including:
Umedica’s manufacturing capabilities are further strengthened by our expertise in Sustained Release Formulations, ensuring consistent and effective therapeutic outcomes.
Our facility has been successfully audited and approved by regulatory agencies across a wide range of global markets, including the USA, Europe, Canada, Australia, UAE
With a strong foundation in quality, compliance, and innovation, Umedica is well-positioned to support the UK healthcare system by supplying high-quality generics tailored to the needs of patients and healthcare providers alike.
